Merit Medical Systems Revenue 2010-2023 | MMSI

Merit Medical Systems revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Merit Medical Systems Annual Revenue
(Millions of US $)
2023 $1,257
2022 $1,151
2021 $1,075
2020 $964
2019 $995
2018 $883
2017 $728
2016 $604
2015 $542
2014 $510
2013 $449
2012 $394
2011 $359
2010 $297
2009 $257
Merit Medical Systems Quarterly Revenue
(Millions of US $)
2023-12-31 $325
2023-09-30 $315
2023-06-30 $320
2023-03-31 $298
2022-12-31 $293
2022-09-30 $287
2022-06-30 $295
2022-03-31 $275
2021-12-31 $278
2021-09-30 $267
2021-06-30 $280
2021-03-31 $249
2020-12-31 $258
2020-09-30 $244
2020-06-30 $218
2020-03-31 $244
2019-12-31 $258
2019-09-30 $243
2019-06-30 $256
2019-03-31 $238
2018-12-31 $233
2018-09-30 $222
2018-06-30 $225
2018-03-31 $203
2017-12-31 $191
2017-09-30 $179
2017-06-30 $187
2017-03-31 $171
2016-12-31 $158
2016-09-30 $157
2016-06-30 $151
2016-03-31 $138
2015-12-31 $138
2015-09-30 $136
2015-06-30 $138
2015-03-31 $130
2014-12-31 $133
2014-09-30 $129
2014-06-30 $129
2014-03-31 $119
2013-12-31 $120
2013-09-30 $115
2013-06-30 $110
2013-03-31 $104
2012-12-31 $102
2012-09-30 $96
2012-06-30 $101
2012-03-31 $96
2011-12-31 $91
2011-09-30 $90
2011-06-30 $91
2011-03-31 $87
2010-12-31 $81
2010-09-30 $73
2010-06-30 $75
2010-03-31 $67
2009-12-31 $67
2009-09-30 $67
2009-06-30 $65
2009-03-31 $58
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.272B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00